M&A - Aimei Health Technology Co., Ltd.

Form Type: 10-Q

Filing Date: 2025-05-14

Corporate Action: Merger

Type: Update

Accession Number: 000164117225010315

Filing Summary: Aimei Health Technology Co., Ltd. has entered into a definitive Business Combination Agreement to merge with United Hydrogen Group Inc. and related entities, with the merger being an essential part of the process to finalize its initial business combination. As of May 14, 2025, the Company had 6,121,733 ordinary shares issued and outstanding. The financial statements reflect the Company's current status as a blank check company focused on healthcare innovation. The Company is obligated to consummate a business combination within a set timeframe, which has been extended multiple times. The latest extension allows until June 6, 2025, for completing these arrangements. Recent shareholder actions included 2,904,267 shares redeemed at approximately $10.77 each. Additionally, details of the financial performance, such as total assets of $43.6 million and net income of $184,662 for the quarter, are provided, alongside ongoing implications related to postponed operations until the approved business combination is realized.

Form Type: 10-K

Filing Date: 2025-03-28

Corporate Action: Merger

Type: New

Accession Number: 000164117225001169

Filing Summary: Aimei Health Technology Co., Ltd. filed its Form 10-K for the fiscal year ended December 31, 2024. The company is a Cayman Islands exempted company formed as a blank check entity aimed at acquiring businesses, primarily in the biopharmaceutical and medical technology sectors. A significant development in the report is the proposed merger with United Hydrogen Group Inc. through a definitive Business Combination Agreement. The merger includes two sequential mergers: the First Merger with United Hydrogen and the Second Merger where Aimei will become a wholly-owned subsidiary of the newly formed public entity. The agreement outlines conditions for closing, including regulatory approvals, shareholder votes, and financial requirements, indicating a robust structure for the transaction. The report also details the company's IPO which raised $60 million, and the establishment of a trust account for the proceeds, pending the completion of the business combination.